Similar articles

• Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study.

  Kohli A, Osinusi A, Sims Z, Nelson A, Meissner EG, Barrett LL, Bon D, Marti MM, Silk R, Kotb C, Gross C, Jolley TA, Sidharthan S, Petersen T, Townsend K, Egerson D, Kapoor R, Spurlin E, Sneller M, Proschan M, Herrmann E, Kwan R, Teferi G, Talwani R, Diaz G, Kleiner DE, Wood BJ, Chavez J, Abbott S, Symonds WT, Subramanian GM, Pang PS, McHutchison J, Polis MA, Fauci AS, Masur H, Kottilil S. Kohli A, et al. Lancet. 2015 Mar 21;385(9973):1107-13. doi: 10.1016/S0140-6736(14)61228-9. Epub 2015 Jan 13. Lancet. 2015. PMID: 25591505 Free PMC article. Clinical Trial.
• Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration.

  Townsend K, Meissner EG, Sidharthan S, Sampson M, Remaley AT, Tang L, Kohli A, Osinusi A, Masur H, Kottilil S. Townsend K, et al. AIDS Res Hum Retroviruses. 2016 May;32(5):456-62. doi: 10.1089/AID.2015.0170. Epub 2015 Dec 15. AIDS Res Hum Retroviruses. 2016. PMID: 26559180 Free PMC article. Clinical Trial.
• Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS).

  Bourlière M, Bronowicki JP, de Ledinghen V, Hézode C, Zoulim F, Mathurin P, Tran A, Larrey DG, Ratziu V, Alric L, Hyland RH, Jiang D, Doehle B, Pang PS, Symonds WT, Subramanian GM, McHutchison JG, Marcellin P, Habersetzer F, Guyader D, Grangé JD, Loustaud-Ratti V, Serfaty L, Metivier S, Leroy V, Abergel A, Pol S. Bourlière M, et al. Lancet Infect Dis. 2015 Apr;15(4):397-404. doi: 10.1016/S1473-3099(15)70050-2. Epub 2015 Mar 13. Lancet Infect Dis. 2015. PMID: 25773757 Clinical Trial.
• The Challenge of Treating Children With Hepatitis C Virus Infection.

  Indolfi G, Thorne C, El Sayed MH, Giaquinto C, Gonzalez-Peralta RP. Indolfi G, et al. J Pediatr Gastroenterol Nutr. 2017 Jun;64(6):851-854. doi: 10.1097/MPG.0000000000001589. J Pediatr Gastroenterol Nutr. 2017. PMID: 28362694 Review.
• Clinical Pharmacokinetics and Pharmacodynamics of Ledipasvir/Sofosbuvir, a Fixed-Dose Combination Tablet for the Treatment of Hepatitis C.

  German P, Mathias A, Brainard D, Kearney BP. German P, et al. Clin Pharmacokinet. 2016 Nov;55(11):1337-1351. doi: 10.1007/s40262-016-0397-0. Clin Pharmacokinet. 2016. PMID: 27193156 Review.